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Abstract. Translating potential disease biomarkers between multi-species
’omics’ experiments is a new direction in biomedical research. The ex-
isting methods are limited to simple experimental setups such as ba-
sic healthy-diseased comparisons. Most of these methods also require
an a priori matching of the variables (e.g., genes or metabolites) be-
tween the species. However, many experiments have a complicated multi-
way experimental design often involving irregularly-sampled time-series
measurements, and for instance metabolites do not always have known
matchings between organisms. We introduce a Bayesian modelling frame-
work for translating between multiple species the results from ’omics’ ex-
periments having a complex multi-way, time-series experimental design.
The underlying assumption is that the unknown matching can be in-
ferred from the response of the variables to multiple covariates including
time.
Keywords: Cross-species translation, Data integration, Hidden Markov Model,
Multi-way experimental design, Time-series, Translational medicine
1 Introduction
Cross-species analysis of biological data is an increasingly important direction
in biological research. The analysis calls for multivariate methods, since ’omics’
technologies, such as transcriptomics and metabolomics, enable studying the dy-
namic response of biological organisms in various conditions, including various
time points during disease progression. An important reserach problem of trans-
lational medicine is translating potential biomarkers for disease between species.
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This would ultimately allow mapping phenotypes between model organisms and
actual human experiments.
The basic experimental design in searching for disease biomarkers is the one-
way comparison of healthy and diseased populations. At the simplest, biomarkers
can be translated between species by comparing lists of p-values of simple dif-
ferential expression. Most existing cross-species analysis methods are limited to
such simple designs [8]. A further limitation of most existing methods is that
they require an a priori matching of variables (genes) between the organisms.
Such orthology information is not always available, especially in metabolomics
where the mapping of metabolites between organisms has barely started, and is
an interesting research problem in itself.
Most biological experiments have a multi-way experimental design, where
healthy and diseased populations are further divided into subpopulations accord-
ing to additional covariates such as gender, treatment groups, age, measurement
times etc. A usual approach for dealing with the additional covariates is strati-
fying the diseased-healthy comparison; a typical example is comparing healthy
and diseased males and females separately. The standard statistical methods
for properly dealing with multi-way designs, are Analysis of Variance (ANOVA)
and its multivariate generalization (MANOVA). While studying the effects of all
the covariates on the data makes the analysis slightly more complicated, more
information can be gained from each species to be used in the translation. Un-
fortunately, there exist no earlier proper tools for utilizing the information of
the effects of multiple covariates on the data in cross-species analysis.
Furthermore, time-series experiments are becoming more and more common
in clinical studies searching for disease biomarkers. Whereas in some cases the
measurement times of such experiments are regular and allow a “neat and easy”
data analysis, this is often not the case. In clinical follow-up studies, such as [13],
measurement times are often irregular due to practical reasons of data collection,
and there are missing time points. Also, in follow-up studies spanning timescales
of years, individuals have been shown to develop into metabolic developmental
states at an individual pace [12]. In addition, life spans of different organisms,
such as man and mouse, are very different resulting in very different measure-
ment times. These complications call for a possibility to align the time-series.
All of these factors combined cause remarkable challenges for cross-species data
analysis.
Instead of searching for single molecule biomarkers, which have a high risk
of false positives, we concentrate on finding combinations of similarly-behaving
biomarkers, which is a way towards treating a transcriptomic or a metabolic
profile as a fingerprint of the clinical status of the organism. For this, multivari-
ate statistics is needed. In this paper, we will now show how the data analysis
problem can be formulated as a new multivariate ANOVA-type model in the
case where data comes from multiple sources (species) and one of the variables,
namely the time, has a previously unknown structure (alignment).
In this paper, we will present a formal framework for cross-species analysis
of ’omics’ data in the case of a multi-way, time-series experimental design. This
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methodology can be directly used for finding previously unknown matching of
groups of variables between the species based on the data. In contrast to many-
step approaches, the whole modelling is done in a single, unified, multivariate
Bayesian model. The framework has estimation of uncertainty and dimensional-
ity reduction built-in to overcome the main challenge: high dimensionality and
small sample-size. The central underlying assumption is that the actual link be-
tween the variables of the different species can be inferred from a similar response
of the variables to multi-way covariates.
Previous work in cross-species analysis
Until now, meta-analysis of microarray data has been the major approach to
cross-species studies in biology [8]. Plenty of meta-analyses have been done by
either comparing lists of differentially expressed genes between several species, or
by comparing expression levels of known gene orthologs between the species. So
far, mainly highly-controlled cell cycle studies have been analyzed across several
species and no attention has been paid to multi-way designs.
One step towards translational analysis has been taken by Lucas et al. [10,11].
To help finding biomarkers from an in vivo experiment, they incorporated prior
knowledge from results of an in vitro study analyzed with the same method.
Like ours, their approach is based on generative Bayesian modeling of factors
and can handle multiple covariates. Their approach does not, however, consider
time-series cases with unaligned time nor the case without any a priori matching
between the variables.
A probabilistic model based on Gaussian random fields has been applied
to two-species expression data [9]. This work combined differential expression
scores from different species, cell types, and pathogens utilizing homology infor-
mation. In [6] the task was to query large databases of micro-array experiments
to identify similar experiments in different species, by utilizing partially known
orthology information. In [7] time-series micro-array data from multiple species
was used to discover causal relations between genes to discover conserved regu-
latory networks. Also this approach naturally needs a priori known matching of
orthologous genes.
A standard method for finding similarities between several data sets is canon-
ical correlation analysis (CCA)[2]. CCA assumes paired samples over the data
set and thus is not directly applicable for the translation problem, where the
samples (patients) are different over species. A simple iterative method for pair-
ing genes has been developed in [14,15]. In the case the genes are samples in the
data matrix, optimal pairing of genes is sought by maximizing the dependency
between the data sets estimated by CCA. A very similar method was recently
used for regulatory network inference [1]. No prior matching of variables or sam-
ples is assumed, and the method attempts to find both iteratively by alternating
between matching of variables and matching of samples using a closely related
method Co-Inertia analysis. These methods do not, however, take into account
covariate information (including measurement time) of the samples, nor different
time resolution of the covariates.
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In summary: none of the existing approaches can take into account a multi-
way time-series covariate structure or exploit it to find previously unknown
matchings between the variables without any a priori known matching infor-
mation.
2 Model
Our method addresses the problem of translating biomarkers between multiple
species from multi-way time-series experiments with previously unknown match-
ings between the variables (metabolites). We do not assume the samples have a
pairing but our main assumption is that there is a similar multi-way time-series
experimental design in both experiments.
A simple data analysis procedure towards this goal would be doing the uni-
variate multi-way ANOVA analysis separately on the two data sets of the two
species, and comparing the lists of p-values afterwards as a meta-analysis step.
In the two-way case, to explain the covariate-related variation in one species,
say x, the following linear model is usually assumed:
xj |(a,b) = µx + αxa + βxb + (αβ)xab + j . (1)
Here xj is a continuous-valued data vector, observation number j, the µ
x is
the overall (grand) mean, the a and b (a = 0, . . . A and b = 0, . . . B) are the
two independent covariates, such as disease and treatment. The αxa and β
x
b are
parameter vectors describing the covariate-specific effects, called main effects.
The (αβ)xab is a parameter vector describing the interaction effect.
Instead of searching for single-molecule biomarkers, that have a high risk of
false positives, our approach is multivariate, concentrating on finding combina-
tions of biomarkers.
In order to tackle high dimensionality and scarcity of observations, we as-
sume that there are groups of similarly behaving variables (metabolites) in each
species. We then search for correlated groups of metabolites sharing a similar
response to external covariates. These correlated groups (clusters) are therefore
assumed to be shared between the species. Underlying this process is the assump-
tion that similarity of multi-way behavior of groups of metabolites indicates a
cross-species mapping of the metabolites.
We have taken an ambitious goal by building a unified Bayesian model that
integrates the separate multi-way experiments from multiple species. The model
can be learned jointly by Gibbs sampling.
From the point of view of ANOVA-type modelling the question is how to do
multi-way modelling when the data comes from different sources with different
variables (e.g., man and mouse having different metabolites). The solution is to
consider data “source” as an additional covariate in the multi-way analysis [5].
From the data integration point of view the task is to find dependencies between
the data sets when neither the variables nor the samples have been paired.
There is, however, a shared multi-way covariate structure in the data sets, and
it is utilized to find the mapping of groups of variables. We study additionally
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the case where one of the covariates, time, has a previously unknown structure
due to unknown time alignments. It will be shown that the alignments can be
found simultaneously within the whole unified model.
The model we develop for this task is an extension of our recently pub-
lished multi-way modelling methods [4,3,5]. In [4], we presented a method for
multi-way ANOVA-type modelling in “small sample-size n, high dimensionality
p ”-conditions in the case of standard covariates, such as disease, treatment,
and gender. The solution is to use regularized factor analysis for dimension-
ality reduction, such that each variable is assumed to come from one factor
only. The effects of multi-way covariates αa,βb, (αβ)ab are then estimated in
the low-dimensional latent factor space. Each latent factor represents a group of
correlated variables. The model is
xlatj ∼ N (αa + βb + (αβ)ab, I)
xj ∼ N (µ + Vxlatj ,Λ) . (2)
Here xj is a p-dimensional data vector, V is the projection matrix, and x
lat
j
is the low-dimensional latent variable, Λ is a diagonal residual variance matrix
with diagonal elements σ2i .
In [3], we further extended this framework into integrating data sources with
paired samples, such as having measurements from multiple tissues of each in-
dividual. In [5], we first extended [4] into time-series cases with unknown align-
ments, such that these alignments can be learned simultaneously with the multi-
way modelling task. In [5], we also presented the basic principle and a simplified
model of how the multi-way modelling framework can be extended into trans-
lational modelling. This case is much more difficult than [3], because samples
have not been paired between the data sources; For example, the pairing of one
time-point of an individual test mouse and a time-point from one of the human
patients cannot be assumed. In [5] we concentrated on finding a shared response
of the variables to one covariate only; the aligned time. In this paper we now
proceed by presenting the full translational model where, in addition to aligned
time, there are other covariates, such as disease. Also, in this paper we separate
the time- and disease behavior into shared and species-specific effects.
2.1 Modelling time-series measurements from multiple populations
with regular measurement times
Let us now consider modelling data from time-series measurements from diseased
and healthy populations in one species. If the measurement times are fixed and
individuals can be assumed to have similar aging development, the data analysis
can be seen as a two-way design and modelled with a linear model. When mod-
elling the effects of time and other covariates on low-dimensional latent factors,
each factor representing one correlated group of variables [4], we can use the
model
xlatj |(t,b) = αt + βb + (αβ)tb + noise. (3)
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We denote from now on the time-point by t, the disease status by b = {0, 1}, the
effect of time by αt, the effect of disease by βb, and the interaction of time and
disease (αβ)tb. The last one is the most interesting, denoting the time-dependent
disease effects.
2.2 Modelling time-series measurements from multiple populations
with irregular measurement times
This work is motivated by the fact that in many real-world sparsely collected
time-series datasets, especially from large-cohort human clinical studies, mea-
surement times can be irregular within and between individuals; one particular
state-of-the-art clinical lipidomic study is [13], on which we now concentrate.
This study followed a set of patients; some of them remained healthy, some
developed into type 1 Diabetes. Furthermore, it was shown in [12] that individ-
uals progress into different age-related metabolic states at their indivual pace.
This phenomenon can be modelled by assuming that there are underlying la-
tent metabolomic development states and individuals progress into these states
in their individual pace [12]. The underlying states were modelled by Hidden
Markov Models (HMM), where the observed metabolic profiles are assumed to
be emitted by the underlying states. This modelling assumption also deals with
the problem of aligning irregular measurements.
The important problem now is how to separate the effects of disease from the
individual aging changes. In [12] the HMM model was trained separately for the
healthy population and the diseased population, and such an approach cannot
fully answer this question.
The model [5] that can separate these two effects is
xlatj |state(j,t)=s,b ∼ N (αs + βb + (αβ)sb, I), (4)
where s is the latent development state (HMM-state), αs, is the effect of aligned
HMM-time and (αβ)sb is the most interesting effect, the interaction of “HMM-
time” and disease. We showed in [5] that it is possible to simultaneously estimate
the terms in the model (4) and learn the alignments of the time-series into
the HMM development states. We assume a linear HMM-chain, allowing only
self-transitions and transitions into the next state. The probability of the t:th
time-point of individual j being in state s is
p(s(j, t) = s) = p (s(j, t)|s(j, t− 1)) p (xlatj |αs + βb + (αβ)sb) p (s(j, t+ 1)|s(j, t)) .
(5)
If more covariates are present in the study, it is straightforward to extend the
model (4) by additional terms.
2.3 Translating biomarkers between species from time-series
measurements from multiple populations with irregular
measurement times
We now propose that translation of results between multiple species, from multi-
way time-series experiments, should be done by finding groups of similarly behav-
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ing variables (metabolites) in both species that respond similarly into multi-way
covariates. A data matrix representation of the data analysis problem and plate
diagram of the Bayesian model are shown in Figure 1. We introduce a modeling
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Fig. 1. a) Data matrix representation of the data analysis problem. (b) Plate diagram
of the Bayesian graphical model. The set θs = {αs,αxs ,αys , (αβ)sb, (αβ)xsb, (αβ)ysb}
contains all latent variables describing the corresponding HMM state. The state of
each sample is determined by an observed covariate b and an unobserved covariate s.
framework that can do this task, even in the complicated case of having irregular
time-series measurements that require alignment into hidden metabolic states.
The model makes the very flexible assumption [5] that the observed data
vectors in the two species with different variables, x and y, are generated by
latent effects according to
x = µx + fx(αs + βb + (αβ)sb) + f
x(αxs + β
x
b + (αβ)
x
sb) + ,
y = µy + fy(αs + βb + (αβ)sb) + f
y(αys + β
y
b + (αβ)
y
sb) +  , (6)
where αs, βb, (αβ)sb are the shared effects of HMM-time, disease and inter-
action of HMM-time and disease, respectively, αxs , β
x
b and (αβ)
x
sb and are the
species -specific effects of HMM-time, disease and interaction of HMM-time and
disease, respectively, and likewise for species y. The variable-spaces of x and y
are different, and therefore also the dimensions of the latent variables of xlatj and
ylatj representing groups of correlated variables in both species, need not match.
For this reason, the latent effects of the covariates have to be projected into the
actual observed data spaces x and y through previously unknown projections
fx and fy, that will be learned jointly with the model.
The translational problem now becomes: Does some dimension of xlatj re-
spond to the covariates s and b similarly as one of ylatj . If it does, one can
represent this behavior with shared effects (αs,βb, (αβ)sb). The interpretation
is that a cluster of correlated variables in x represented by the dimension of
xlatj matches with a cluster of correlated variables in y. Such dimensions can
be considered as multi-species biomarkers. If there is no match, the response to
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the external covariates is modelled by species-specific effects (αxs ,β
x
b , (αβ)
x
sb)).
With this framework, we are able to estimate confidence of the shared effects.
2.4 Matching problem
We propose the following measure for quantifying the quality of the match be-
tween two clusters from different datasets: whether the matching is better than
an average matching (over other pairs). On a meta-level the measure is intu-
itively appealing in the spirit of permutation tests, and it can be formulated
more exactly by specifying what we mean by “better.” We will use probabilistic
modeling to measure relative goodness below.
The matching problem of the clusters is a combinatorial problem, where pos-
sible configurations of pairs need to be evaluated, judging for each pair how
similarly they respond to multi-way covariates. We resort to an iterative algo-
rithm that attempts to change the matching of one cluster at a time. Choosing
a candidate pair, we compare its goodness to an average pair (uniformly se-
lected having one same endpoint), and accept forming a link between them by a
Metropolis criterion that compares the likelihoods of the two pairings. A reverse
operation is to attempt to break a link by comparing an existing link between
two clusters to an average (random) pair. The goodness (likelihood) of a pair is
evaluated by a shared multi-way model between the clusters. Clusters with no
pairs are modelled as specific effects. Averaging over the iterations, we can esti-
mate the probability for matchings and the “shapes” of the multi-way effects. A
high probability of a specific pair indicates a found matching. A high probability
for being modelled as a specific effect indicates the cluster has no pair.
3 Results
We illustrate the method with generated data and lipidomic time series data
with a two-way, time-series experimental design. In the experiments, we neglect
the static disease effects βb and assume all the disease effects are due to HMM-
state-specific disease effects (αβ)sb.
3.1 Generated data
We generated from the model two data sets X and Y with no pairing of samples
but only a shared two-way design. There are 11 separate time-series (“patients”)
in both of the two data matrices, each series consisting of 5 to 15 time points. This
results in 108 and 115 samples, and data matrices are 200- and 210-dimensional.
The latent factors xlatj and y
lat
j are 3- and 4-dimensional, respectively. The data
in each population is generated from a shared HMM-chain with 5 states. We
generate three covariate effects into the data: (i) a shared temporal effect αs as
0, +0.5, +1, +1.5, +2 in one cluster of data set X and one cluster of data set Y,
(ii) a shared interaction effect (αβ)sb as 0, −0.5, −1, −1.5, −2 in another cluster
of X and another cluster of Y, (iii) a specific temporal effect αys as 0, −0.5, −1,
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−1.5, −2 in yet another cluster of data set Y. Patterns (i) and (ii) are the only
behavior that is shared between the two data sets representing the two species,
and the model should be able to learn the correct pairing of variable clusters
based on this similarity. We use the proposed model to jointly align the samples
into HMM states, learn the clusters of variables, search for the possible pairing
of the clusters between the two data sets, and model the ANOVA-type effects
acting on the found clusters. We chose a priori a model with 5 HMM states.
For the analysis we discarded the first 5 000 samples from the Gibbs sampler as
a burn-in period and after this ran the model for another 5 000 Gibbs samples
of which we saved every 5th sample to obtain a total of 1 000 Gibbs samples to
approximate the underlying posterior distribution.
Our model finds the previously generated clusters without mistakes (see
Fig. 2). It also connects the X-cluster 1 to Y-cluster 3 and X-cluster 3 to Y-
cluster 2 by estimating them to be linked in 89.9 % and 47.9 % of posterior
samples, respectively. The generated shared and specific effects are detected as
expected and no false positive effects are found.
3.2 Lipidomic time-series data
We then validate the model with a real lipidomic data set, consisting of time-
series measurements from a recently published type 1 diabetes (T1D) follow-
up study [13]. In the data, there are 71 healthy patients and 53 patients that
later developed into T1D. For each time-series, there are 3–29 time points from
irregular intervals. For this validation study, we randomly divide the individuals
into two non-overlapping data sets X and Y. We then study, whether we can
find a similar response to the covariates disease and HMM-time, and a matching
between those clusters from the two data sets that respond to these covariates.
Again, we a priori chose a model with 5 HMM states. We learned a two-way
model for the data, where the first way is “HMM-time” and the second way
is “disease”. Lipids were assigned into 6 clusters. We discarded 10 000 burn-
in samples and collected 10 000 Gibbs samples of which we saved every 10th
sample to obtain a total of 1 000 Gibbs samples approximating the posterior
distribution.
The model integrates the datasets X and Y by learning the HMM-time effects
αs and interaction effects (αβ)sb. Clusters of lipids and effects found (Fig. 3)
were similar as in our previous publication [5]. The model finds three matching
clusters between X and Y responding similarly to the external covariates, thus
linking the same lipids between the two subsets of data without prior knowledge.
The corresponding clusters were paired in 10–12 % of posterior samples, which
is higher than for other combinations of pairing (0–11 %). Naturally the method
does not find matchings for clusters that do not respond to external covariates.
A group of triglycerol (TAG) and two groups of glycerophosphocholine (Gp-
Cho) were strongly paired to their counterparts. On real data, the result is
naturally not as good as on generated data, since the effects are weaker.
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Fig. 2. Pairing results from generated time-series data. Shown are the main effects
(HMM-time; left) and interaction effects (right). Topmost, the generated effects are
illustrated. Lower, the table of estimated effects shows shared (top-right area) and
specific (left column and bottom row) effects for both types of effects. Rows and columns
in the area of shared effects correspond to clusters in data sets X and Y, respectively.
The found true pairing is highlighted by a red box. Value on top of each plot shows
the percentage of posterior samples where the effect is found. An effect above or below
zero is considered significant.
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Fig. 3. Pairing results from lipidomic time-series data. Only the main effects αs are
shown. The true pairings found are highlighted by red boxes. The table shows shared
(top-right area) and specific (left column and bottom row) effects estimated by the
model. Rows and columns in the area of shared effects correspond to clusters in data
sets X and Y, respectively. An effect (boxplot) consistently above or below zero is
considered significant. Value on top of each plot shows the percentage of iterations
where the clusters were matched.
4 Discussion
We presented a novel method for translating biomarkers between multiple species
from multi-way, time-series experiments. The case we addressed is when there
are no a priori known matching between the variables in the two datasets, but
only a similar experimental design. The method estimates ANOVA-type multi-
way covariate effects for clusters of variables, and identifies and separates effects
that are shared between the species and effects that are species-specific.
For biological data, the task is harder than for generated data. Probabilities of
matched shared effects were lower for biological data, which is caused by the fact
that the covariate effects in a biological experiment are weaker, making it more
challenging for the method to find the similarity between the data sets. The study
with lipidomic T1D data showed, however, that the method is able to extract
similarities between non-paired biological data sets. The approach presented can
be naturally extended to multiple ways (covariates) and to multiple species.
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